Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.

Colorectal cancer is the 2nd leading cause of cancer-related deaths in the world. The mechanisms underlying CRC development, progression, and resistance to treatment are complex and not fully understood. The immune response in the tumor microenvironment has been shown to play a significant role in m...

Full description

Bibliographic Details
Main Authors: Apryl S Saunders, Dawn E Bender, Anita L Ray, Xiangyan Wu, Katherine T Morris
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247233
_version_ 1797745306406748160
author Apryl S Saunders
Dawn E Bender
Anita L Ray
Xiangyan Wu
Katherine T Morris
author_facet Apryl S Saunders
Dawn E Bender
Anita L Ray
Xiangyan Wu
Katherine T Morris
author_sort Apryl S Saunders
collection DOAJ
description Colorectal cancer is the 2nd leading cause of cancer-related deaths in the world. The mechanisms underlying CRC development, progression, and resistance to treatment are complex and not fully understood. The immune response in the tumor microenvironment has been shown to play a significant role in many cancers, including colorectal cancer. Colony-stimulating factor 3 (CSF3) has been associated with changes to the immune environment in colorectal cancer animal models. We hypothesized that CSF3 signaling would correlate with pro-tumor tumor microenvironment changes associated with immune infiltrate and response. We utilized publicly available datasets to guide future mechanistic studies of the role CSF3 and its receptor (CSF3R) play in colorectal cancer development and progression. Here, we use bioinformatics data and mRNA from patients with colon (n = 242) or rectal (n = 92) cancers, obtained from The Cancer Genome Atlas Firehose Legacy dataset. We examined correlations of CSF3 and CSF3R expression with patient demographics, tumor stage and consensus molecular subtype classification. Gene expression correlations, cell type enrichment, Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data scores and Gene Ontology were used to analyze expression of receptor and ligand, tumor microenvironment infiltration of immune cells, and alterations in biological pathways. We found that CSF3 and CSF3R expression is highest in consensus molecular subtype 1 and consensus molecular subtype 4. Ligand and receptor expression are also correlated with changes in T cell and macrophage signatures. CSF3R significantly correlates with a large number of genes that are associated with poor colorectal cancer prognosis.
first_indexed 2024-03-12T15:21:26Z
format Article
id doaj.art-05fc14da56ee4e2097333749f729ba07
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-12T15:21:26Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-05fc14da56ee4e2097333749f729ba072023-08-11T05:30:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01162e024723310.1371/journal.pone.0247233Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.Apryl S SaundersDawn E BenderAnita L RayXiangyan WuKatherine T MorrisColorectal cancer is the 2nd leading cause of cancer-related deaths in the world. The mechanisms underlying CRC development, progression, and resistance to treatment are complex and not fully understood. The immune response in the tumor microenvironment has been shown to play a significant role in many cancers, including colorectal cancer. Colony-stimulating factor 3 (CSF3) has been associated with changes to the immune environment in colorectal cancer animal models. We hypothesized that CSF3 signaling would correlate with pro-tumor tumor microenvironment changes associated with immune infiltrate and response. We utilized publicly available datasets to guide future mechanistic studies of the role CSF3 and its receptor (CSF3R) play in colorectal cancer development and progression. Here, we use bioinformatics data and mRNA from patients with colon (n = 242) or rectal (n = 92) cancers, obtained from The Cancer Genome Atlas Firehose Legacy dataset. We examined correlations of CSF3 and CSF3R expression with patient demographics, tumor stage and consensus molecular subtype classification. Gene expression correlations, cell type enrichment, Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data scores and Gene Ontology were used to analyze expression of receptor and ligand, tumor microenvironment infiltration of immune cells, and alterations in biological pathways. We found that CSF3 and CSF3R expression is highest in consensus molecular subtype 1 and consensus molecular subtype 4. Ligand and receptor expression are also correlated with changes in T cell and macrophage signatures. CSF3R significantly correlates with a large number of genes that are associated with poor colorectal cancer prognosis.https://doi.org/10.1371/journal.pone.0247233
spellingShingle Apryl S Saunders
Dawn E Bender
Anita L Ray
Xiangyan Wu
Katherine T Morris
Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
PLoS ONE
title Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
title_full Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
title_fullStr Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
title_full_unstemmed Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
title_short Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
title_sort colony stimulating factor 3 signaling in colon and rectal cancers immune response and cms classification in tcga data
url https://doi.org/10.1371/journal.pone.0247233
work_keys_str_mv AT aprylssaunders colonystimulatingfactor3signalingincolonandrectalcancersimmuneresponseandcmsclassificationintcgadata
AT dawnebender colonystimulatingfactor3signalingincolonandrectalcancersimmuneresponseandcmsclassificationintcgadata
AT anitalray colonystimulatingfactor3signalingincolonandrectalcancersimmuneresponseandcmsclassificationintcgadata
AT xiangyanwu colonystimulatingfactor3signalingincolonandrectalcancersimmuneresponseandcmsclassificationintcgadata
AT katherinetmorris colonystimulatingfactor3signalingincolonandrectalcancersimmuneresponseandcmsclassificationintcgadata